Elevated levels of IL-17A und IL-17F have been found in patients with IBD and the increased concentration of IL-17A within the lamina propria of patients with Crohn’s disease suggested a possible therapeutic target. The gene discussed is IL17A; the disease is inflammatory bowel disease.